REFERENCES
- Watson M, Abbott KC, Yuan CM. Damned if you do, damned if you don’t: potassium binding resins in hyperkalemia. Clin J Am Soc Nephrol. 2010;5:1723–1726.
- Evans KJ, Greenberg A. Hyperkalemia: a review. J Intensive Care Med. 2005;20:272–290.
- Sterns RH, Rojas M, Bernstein P, Chennupati S. Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol. 2010;21:733–735.
- McGowan CE, Saha S, Chu G, Resnick MB, Moss SF. Intestinal necrosis due to sodium polystyrene sulfonate (kayexalate) in sorbitol. South Med J. 2009;102(5):493–497.
- Putcha N, Allon M. Management of hyperkalemia in dialysis patients. Semin Dial. 2007;20(5):431–439.
- Product Information (Sanofi-Aventis). Calcium resonium. 2008. Available at: http://www.medicines.ie/medicine/5114/SPC/Calcium + Resonium/. Accessed March 20, 2012.
- Gruy-Kapral C, Emmett M, Santa Ana CA, Porter JL, Fordtran JS, Fine KD. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol. 1998;9:1924–1930.